216 related articles for article (PubMed ID: 19398012)
1. Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues.
Schroeder RP; van Weerden WM; Bangma C; Krenning EP; de Jong M
Methods; 2009 Jun; 48(2):200-4. PubMed ID: 19398012
[TBL] [Abstract][Full Text] [Related]
2. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
[TBL] [Abstract][Full Text] [Related]
3. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
4. MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor.
Parry JJ; Andrews R; Rogers BE
Breast Cancer Res Treat; 2007 Jan; 101(2):175-83. PubMed ID: 16838112
[TBL] [Abstract][Full Text] [Related]
5. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
[TBL] [Abstract][Full Text] [Related]
6. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
[TBL] [Abstract][Full Text] [Related]
7. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
Stangelberger A; Schally AV; Varga JL; Zarandi M; Szepeshazi K; Armatis P; Halmos G
Clin Cancer Res; 2005 Jan; 11(1):49-57. PubMed ID: 15671527
[TBL] [Abstract][Full Text] [Related]
9. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.
Yu Z; Carlucci G; Ananias HJ; Dierckx RA; Liu S; Helfrich W; Wang F; de Jong IJ; Elsinga PH
Amino Acids; 2013 Feb; 44(2):543-53. PubMed ID: 22833158
[TBL] [Abstract][Full Text] [Related]
11. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
Markwalder R; Reubi JC
Cancer Res; 1999 Mar; 59(5):1152-9. PubMed ID: 10070977
[TBL] [Abstract][Full Text] [Related]
12. Androgen-regulated gastrin-releasing peptide receptor expression in androgen-dependent human prostate tumor xenografts.
Schroeder RP; de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Breeman WA; Krenning EP; de Jong M
Int J Cancer; 2010 Jun; 126(12):2826-34. PubMed ID: 19876914
[TBL] [Abstract][Full Text] [Related]
13. A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues.
Schroeder RP; Müller C; Reneman S; Melis ML; Breeman WA; de Blois E; Bangma CH; Krenning EP; van Weerden WM; de Jong M
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1386-96. PubMed ID: 20182713
[TBL] [Abstract][Full Text] [Related]
14. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
Maina T; Nock BA; Zhang H; Nikolopoulou A; Waser B; Reubi JC; Maecke HR
J Nucl Med; 2005 May; 46(5):823-30. PubMed ID: 15872357
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.
Höhne A; Mu L; Honer M; Schubiger PA; Ametamey SM; Graham K; Stellfeld T; Borkowski S; Berndorff D; Klar U; Voigtmann U; Cyr JE; Friebe M; Dinkelborg L; Srinivasan A
Bioconjug Chem; 2008 Sep; 19(9):1871-9. PubMed ID: 18754574
[TBL] [Abstract][Full Text] [Related]
16. Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.
Cai QY; Yu P; Besch-Williford C; Smith CJ; Sieckman GL; Hoffman TJ; Ma L
Prostate; 2013 Jun; 73(8):842-54. PubMed ID: 23280511
[TBL] [Abstract][Full Text] [Related]
17. MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.
Rogers BE; Bigott HM; McCarthy DW; Della Manna D; Kim J; Sharp TL; Welch MJ
Bioconjug Chem; 2003; 14(4):756-63. PubMed ID: 12862428
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.
Carlucci G; Ananias HJ; Yu Z; Hoving HD; Helfrich W; Dierckx RA; Liu S; de Jong IJ; Elsinga PH
Mol Pharm; 2013 May; 10(5):1716-24. PubMed ID: 23590837
[TBL] [Abstract][Full Text] [Related]
19. Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate.
Dubuc C; Langlois R; Bénard F; Cauchon N; Klarskov K; Tone P; van Lier JE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2424-7. PubMed ID: 18329268
[TBL] [Abstract][Full Text] [Related]
20. A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier.
Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Pili R; Pomper M; Carducci M; Wagner HN
Bioconjug Chem; 2004; 15(6):1416-23. PubMed ID: 15546210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
